Bond funds are subject to interest rate risk, which is the chance bond prices. overall will decline because of rising interest rates, and credit risk, which is the chance a bond issuer will. fail to pay interest and principal in a timely manner or that negative perceptions of the issuerâs ability to.
New Drug Treatment for IBS in Women. NOTE: On March 30, 2007 the FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years of age with chronic constipation.
IBRANCE is a prescription medicine that is used along with the medicine letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as the first hormone-based therapy for their metastatic disease.